Daniel Spiegelman
Overview
Daniel Spiegelman received an average of $5M in total compensation, including $494K in salary, at BioMarin Pharmaceutical from 2012 to 2020.
2020BioMarin PharmaceuticalFormer Executive Vice President, Chief Financial Officer
2019BioMarin PharmaceuticalFormer Executive Vice President, Chief Financial Officer
2018BioMarin PharmaceuticalExecutive Vice President, Chief Financial Officer
2017BioMarin PharmaceuticalExecutive Vice President, Chief Financial Officer
2016BioMarin PharmaceuticalExecutive Vice President, Chief Financial Officer
2015BioMarin PharmaceuticalExecutive Vice President, Chief Financial Officer
2014BioMarin PharmaceuticalExecutive Vice President, Chief Financial Officer
2013BioMarin PharmaceuticalExecutive Vice President, Chief Financial Officer
2012BioMarin PharmaceuticalExecutive Vice President, Chief Financial Officer
Source: SEC filings on April 13, 2021, April 14, 2020, April 23, 2019, April 25, 2017, April 25, 2016, and April 23, 2015.
Related executives
We found 11 more executives who work or worked at BioMarin Pharmaceutical.
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
C Guyer
BioMarin Pharmaceutical
Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
Robert Baffi
BioMarin Pharmaceutical
Former President of Global Manufacturing and Technical Operations
G Davis
BioMarin Pharmaceutical
General Counsel
Stephen Aselage
BioMarin Pharmaceutical